Blog
Hertz Global (HTZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Hertz Global Holdings, Inc. (HTZ) reported revenue of $2 billion, up 10.5% over the same period last year. EPS came in at -$0.72, compared to -$1.12 in the year-ago
Canada Goose (GOOS) Reports Next Week: Wall Street Expects Earnings Growth
Canada Goose (GOOS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Intellia Therapeutics, Inc. (NTLA) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known
TripAdvisor (TRIP) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2026, TripAdvisor (TRIP) reported revenue of $382.4 million, down 3.9% over the same period last year. EPS came in at -$0.11, compared to $0.14 in the year-ago quarter.
Cars.com (CARS) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended March 2026, Cars.com (CARS) reported revenue of $180.22 million, up 0.7% over the same period last year. EPS came in at $0.45, compared to $0.37 in the year-ago quarter.
The
Arrow Electronics (ARW) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Arrow Electronics (ARW) reported revenue of $9.47 billion, up 39% over the same period last year. EPS came in at $5.22, compared to $1.80 in the year-ago quarter.
Klarna (KLAR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
The market expects Klarna (KLAR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is
Commerce.com (CMRC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Commerce.com (CMRC) reported revenue of $86.84 million, up 5.4% over the same period last year. EPS came in at $0.13, compared to $0.07 in the year-ago quarter.
The
Insight Enterprises (NSIT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Insight Enterprises (NSIT) reported revenue of $2.13 billion, up 1.2% over the same period last year. EPS came in at $2.88, compared to $2.06 in the year-ago
Globant (GLOB) Reports Next Week: What You Should Expect
Globant (GLOB) is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Here's What Key Metrics Tell Us About Cushman & Wakefield (CWK) Q1 Earnings
Cushman & Wakefield (CWK) reported $2.54 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 11%. EPS of $0.15 for the same period compares to $0.09 a year
Option Spread Trade on Leading AI Stock Offers 32% Return Potential
KLA Corporation, a Zacks Rank #2 (Buy), has seen its shares surge this year as the company benefits from strong demand for leading-edge logic, high-bandwidth memory (HBM) and advanced packaging
Best Momentum Stock to Buy for May 7th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 7th:
Western Digital WDC: This company, which is a leading developer and manufacturer of
West Pharmaceutical Services (WST) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, West Pharmaceutical Services, Inc. (WST) is looking like an interesting pick, as it just reached a key level of support. WST's 50-day simple moving average crossed
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
Shares of Biodesix, Inc. (BDSX) have gained 5.3% over the past four weeks to close the last trading session at $15, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Think JBT (JBTM) Could Surge 31.85%: Read This Before Placing a Bet
Shares of JBT Marel (JBTM) have gained 4.8% over the past four weeks to close the last trading session at $136.52, but there could still be a solid upside left in the stock if short-term price
Does DAVE INC (DAVE) Have the Potential to Rally 30.52% as Wall Street Analysts Expect?
Shares of Dave Inc. (DAVE) have gained 38.1% over the past four weeks to close the last trading session at $246.37, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade
Shares of Nuvectis Pharma, Inc. (NVCT) have gained 22.9% over the past four weeks to close the last trading session at $10, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Believe Lifezone Metals Limited (LZM) Could Rally 60.32%: Here's is How to Trade
Lifezone Metals Limited (LZM) closed the last trading session at $5.57, gaining 37.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
OFG Bancorp (OFG)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, OFG Bancorp (OFG) could be a good stock pick from a technical perspective. OFG recently experienced a "golden cross" event, which saw its 50-day simple
Does Atlassian (TEAM) Have the Potential to Rally 41.53% as Wall Street Analysts Expect?
Atlassian (TEAM) closed the last trading session at $88.8, gaining 39.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade
Shares of Vor Biopharma Inc. (VOR) have gained 1% over the past four weeks to close the last trading session at $15.9, but there could still be a solid upside left in the stock if short-term price
After Golden Cross, UMB Financial (UMBF)'s Technical Outlook is Bright
From a technical perspective, UMB Financial Corporation (UMBF) is looking like an interesting pick, as it just reached a key level of support. UMBF's 50-day simple moving average crossed above its
How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%
Janux Therapeutics, Inc. (JANX) closed the last trading session at $14.62, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Why Virtu Financial (VIRT) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates


